TABLE 3—
CCU Predictor Variable | EOR (95% CI) | P |
Model 1, 2-mo follow-up | ||
Assigned to intervention group | 1.39 (0.90, 2.13) | .14 |
Baseline CCU | 4.15 (2.36, 7.31) | < .001 |
Age | 0.84 (0.75, 0.95) | .006 |
Ever diagnosed with chlamydia/gonorrhea | 1.14 (0.73, 1.79) | .56 |
Model 2, 6-mo follow-up | ||
Assigned to intervention group | 1.63 (1.07, 2.49) | .02 |
Baseline CCU | 5.07 (2.96, 8.71) | < .001 |
Age | 0.87 (0.78, 0.98) | .017 |
Ever diagnosed with chlamydia/gonorrhea | 0.86 (0.56, 1.32) | .48 |
Model 3, combined 2- and 6-mo follow-ups | ||
Assigned to intervention group | 1.49 (1.06, 2.08) | .02 |
Baseline CCU | 4.55 (2.91, 7.09) | < .001 |
Age | 0.86 (0.79, 0.94) | .001 |
Ever diagnosed with chlamydia/gonorrhea | 1.00 (0.71, 1.41) | .99 |
Note. CCU = correct and consistent use; CI = confidence interval; EOR = estimated odds ratio.